Novo Nordisk Pharma (Taiwan) Ltd.
Novo Nordisk is a leading global healthcare company, founded in 1923 and headquartered in Denmark. Our purpose is to drive change to defeat diabetes and other serious chronic diseases such as obesity and rare blood and endocrine disorders. We do so by pioneering scientific breakthroughs, expanding access to our medicines, and working to prevent and ultimately cure disease.
Novo Nordisk is a leading global healthcare company, founded in 1923 and headquartered in Denmark. Our purpose is to drive change to defeat diabetes and other serious chronic diseases such as obesity and rare blood and endocrine disorders. We do so by pioneering scientific breakthroughs, expanding access to our medicines, and working to prevent and ultimately cure disease.
Healthcare Asia Pharma Awards 2023 Winner: Novo Nordisk Pharma (Taiwan) Ltd.
Healthcare Asia Pharma Awards 2023 Winner: Novo Nordisk Pharma (Taiwan) Ltd.
Novo Nordisk Pharma (Taiwan) Ltd. wins the ESG Programme of the Year - Taiwan award at the Healthcare Asia Pharma Awards 2023.
Novo Nordisk Pharma Taiwan awarded ESG Program of the Year - Taiwan by the Healthcare Asia Pharma Awards
The company's Corporate Social Responsibility awareness programme aims to give back to local communities and take action for environmental improvement.
Most Read
1. How can Asia-Pacific prove medical research is worth the money? 2. AI drug discovery, GLP-1, and the next wave of Hong Kong biotech listings 3. China's healthcare sector set for global breakout 4. China healthcare lags Hong Kong and global markets in 2026 5. Healthway Medical expands with Bridgepoint Health buyResource Center
Read Here
Advertise
Sign Up
Partner Events
Event News
Demand was strong for AI-driven and digital healthcare solutions.
Commentary
AI drug discovery, GLP-1, and the next wave of Hong Kong biotech listings
Beyond symptom control: Redefining IMID care in Malaysia
How decentralised clinical trials can unlock Asia's research potential